![Ultibro® Breezhaler® en monodosis diaria, superior a Seretide® en reducción de exacerbaciones de la EPOC Ultibro® Breezhaler® en monodosis diaria, superior a Seretide® en reducción de exacerbaciones de la EPOC](https://www.espaciosanitario.com/uploads/s1/10/94/95/2/8-novartis-logo.jpeg)
Ultibro® Breezhaler® en monodosis diaria, superior a Seretide® en reducción de exacerbaciones de la EPOC
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry. - Document - Gale Academic OneFile
![Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry. - Abstract - Europe PMC Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8554477/bin/COPD-16-2917-g0001.jpg)
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry. - Abstract - Europe PMC
![Nanoparticle Formulations and Delivery Strategies for Sustained Drug Release in the Lungs - ScienceDirect Nanoparticle Formulations and Delivery Strategies for Sustained Drug Release in the Lungs - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780128211854000026-f16-01-9780128211854.jpg)